Sonova Holding AG designs, develops, manufactures, and distributes hearing systems for adults and children with hearing impairment. More Details
No risks detected for SONV.Y from our risk checks.
Solid track record with adequate balance sheet.
Share Price & News
How has Sonova Holding's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: SONV.Y has not had significant price volatility in the past 3 months.
7 Day Return
US Medical Equipment
1 Year Return
US Medical Equipment
Return vs Industry: SONV.Y underperformed the US Medical Equipment industry which returned 15.2% over the past year.
Return vs Market: SONV.Y underperformed the US Market which returned 12.9% over the past year.
Price Volatility Vs. Market
How volatile is Sonova Holding's share price compared to the market and industry in the last 5 years?
Simply Wall St News
No news available
Is Sonova Holding undervalued compared to its fair value and its price relative to the market?
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: SONV.Y ($46.42) is trading above our estimate of fair value ($38.91)
Significantly Below Fair Value: SONV.Y is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: SONV.Y is good value based on its PE Ratio (27.8x) compared to the US Medical Equipment industry average (50.5x).
PE vs Market: SONV.Y is poor value based on its PE Ratio (27.8x) compared to the US market (18.2x).
Price to Earnings Growth Ratio
PEG Ratio: SONV.Y is poor value based on its PEG Ratio (2.8x)
Price to Book Ratio
PB vs Industry: SONV.Y is overvalued based on its PB Ratio (6.6x) compared to the US Medical Equipment industry average (4.1x).
How is Sonova Holding forecast to perform in the next 1 to 3 years based on estimates from 20 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: SONV.Y's forecast earnings growth (10.1% per year) is above the savings rate (2.2%).
Earnings vs Market: SONV.Y's earnings (10.1% per year) are forecast to grow slower than the US market (23.1% per year).
High Growth Earnings: SONV.Y's earnings are forecast to grow, but not significantly.
Revenue vs Market: SONV.Y's revenue (5.7% per year) is forecast to grow slower than the US market (9.8% per year).
High Growth Revenue: SONV.Y's revenue (5.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: SONV.Y's Return on Equity is forecast to be high in 3 years time (27%)
How has Sonova Holding performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: SONV.Y has high quality earnings.
Growing Profit Margin: SONV.Y's current net profit margins (16.6%) are higher than last year (16.5%).
Past Earnings Growth Analysis
Earnings Trend: SONV.Y's earnings have grown by 10.8% per year over the past 5 years.
Accelerating Growth: SONV.Y's earnings growth over the past year (6.2%) is below its 5-year average (10.8% per year).
Earnings vs Industry: SONV.Y earnings growth over the past year (6.2%) exceeded the Medical Equipment industry -0.2%.
Return on Equity
High ROE: SONV.Y's Return on Equity (24.1%) is considered high.
How is Sonova Holding's financial position?
Financial Position Analysis
Short Term Liabilities: SONV.Y's short term assets (CHF1.2B) exceed its short term liabilities (CHF1.1B).
Long Term Liabilities: SONV.Y's short term assets (CHF1.2B) do not cover its long term liabilities (CHF1.4B).
Debt to Equity History and Analysis
Debt Level: SONV.Y's debt to equity ratio (38.9%) is considered satisfactory.
Reducing Debt: SONV.Y's debt to equity ratio has increased from 0.01% to 38.9% over the past 5 years.
Debt Coverage: SONV.Y's debt is well covered by operating cash flow (106.9%).
Interest Coverage: SONV.Y's interest payments on its debt are well covered by EBIT (157.2x coverage).
What is Sonova Holding current dividend yield, its reliability and sustainability?
Forecast Dividend Yield
Dividend Yield vs Market
Notable Dividend: Unable to evaluate SONV.Y's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate SONV.Y's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if SONV.Y's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if SONV.Y's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: SONV.Y is not paying a notable dividend for the US market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of SONV.Y's dividend in 3 years as they are not forecast to pay a notable one for the US market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Arnd Kaldowski (53 yo)
Mr. Arnd Kaldowski has been the Chief Executive Officer at Sonova Holding AG since April 1, 2018 and its Chief Operating Officer since October 1, 2017 and its Member of Management Board since October 1, 20 ...
CEO Compensation Analysis
Compensation vs Market: Arnd's total compensation ($USD4.02M) is below average for companies of similar size in the US market ($USD11.35M).
Compensation vs Earnings: Arnd's compensation has been consistent with company performance over the past year.
|CEO, COO & Member of Management Board||2.42yrs||CHF3.68m||no data|
|CFO & Member of Management Board||8.08yrs||no data||no data|
|Group VP of Research & Development and Member of Management Board||8.42yrs||no data||no data|
|Group VP of Hearing Instruments Wholesale & Member of Management Board||8.33yrs||no data||no data|
|Group VP of Hearing Instruments Marketing & Member of Management Board||6.08yrs||no data||no data|
|Group VP of Audiological Care & Member of Management Board||3.67yrs||no data||no data|
|Group VP of Corporate HRM & Communications and Member of Management Board||2.92yrs||no data||no data|
|Member of Management Board||1.42yrs||no data||no data|
|Group VP of Operations & Member of Management Board||1.42yrs||no data||no data|
|Director of Investor Relations||no data||no data||no data|
|President of Hearing Instruments Wholesale for US||no data||no data||no data|
|Head of Hear the World Initiative||no data||no data||no data|
Experienced Management: SONV.Y's management team is considered experienced (3.7 years average tenure).
|Independent Chairman||9.5yrs||CHF904.04k||0.086% |
|Independent Non-Executive Director||17.67yrs||CHF310.05k||0.013% |
|Independent Vice Chairman||8.25yrs||CHF313.75k||0.018% |
|Independent Non-Executive Director||6.67yrs||CHF300.79k||0.013% |
|Independent Non-Executive Director||7.25yrs||CHF281.52k||0.015% |
|Non-Executive Independent Director||11.25yrs||CHF317.35k||0.013% |
|Director||0.25yr||no data||no data|
|Independent Non-Executive Director||4.25yrs||CHF300.79k||0.0074% |
Experienced Board: SONV.Y's board of directors are considered experienced (7.3 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Sonova Holding AG's company bio, employee growth, exchange listings and data sources
- Name: Sonova Holding AG
- Ticker: SONV.Y
- Exchange: OTCPK
- Founded: 1947
- Industry: Health Care Equipment
- Sector: Healthcare
- Market Cap: CHF13.203b
- Listing Market Cap: CHF14.404b
- Shares outstanding: 62.43m
- Website: https://www.sonova.com
Number of Employees
- Sonova Holding AG
- Laubisrutistrasse 28
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|PHBN||DB (Deutsche Boerse AG)||Yes||Registered Shares||DE||EUR||Dec 1994|
|SOON||SWX (SIX Swiss Exchange)||Yes||Registered Shares||CH||CHF||Dec 1994|
|SONV.F||OTCPK (Pink Sheets LLC)||Yes||Registered Shares||US||USD||Dec 1994|
|0QPY||LSE (London Stock Exchange)||Yes||Registered Shares||GB||CHF||Dec 1994|
|SONV.Y||OTCPK (Pink Sheets LLC)||UNSP ADR EACH REPR 0.2 ORD||US||USD||Dec 2008|
|PHBA||DB (Deutsche Boerse AG)||UNSP ADR EACH REPR 0.2 ORD||DE||EUR||Dec 2008|
Sonova Holding AG designs, develops, manufactures, and distributes hearing systems for adults and children with hearing impairment. It operates through two segments, Hearing Instruments and Cochlear Implan ...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/09/22 05:39|
|End of Day Share Price||2020/09/21 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.